Autoimmune liver disease triggered by SARS-CoV-2: a case report and review of the literature

• Published in: European review for medical and pharmacological sciences Vol. 28; no. 4; p. 1632
• Main Authors: Fanni, D, Gerosa, C, Serra, G, Miglianti, M, Coghe, F, Van Eyken, P, Faa, G, La Nasa, G, Guido, M
• Format: Journal Article
• Language: English
• Published: Italy 01.02.2024
• Subjects: Bile Duct Diseases; COVID-19 - complications; Hepatitis, Autoimmune - diagnosis; Hepatitis, Autoimmune - drug therapy; Humans; Inflammation; Liver Diseases - diagnosis; Liver Diseases - drug therapy; Liver Diseases - etiology; Middle Aged; SARS-CoV-2; Ursodeoxycholic Acid - therapeutic use

An increasing number of coronavirus disease 2019 (COVID-19) related autoimmune hepatitis (AIH) and autoimmune liver disease (AILD) has been already described so far in the last three years. This rise has set up some diagnostic and therapeutic concerns, although steroid therapy has mostly been effici...